Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists

Huffman, DC; Holmes, Erin R

Abstract

Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists

Author(s): Huffman DC, Holmes Erin R

Issue: Nov/Dec 2006 - Veterinary Compounding

View All Articles in Issue

Page(s): 462-468

Download in electronic PDF format for $75

Abstract

The apparent re-emergence of pharmaceutical compounding as an important part of health care is largely explained by the increasing demand for pharmaceutical preparations that are not commercially available. However, there have been recent discussions among regulatory agencies and various stakeholders of the pharmacy profession as to the safety and efficacy of pharmaceutical compounding, and how compounding should best be regulated. In light of this discussion, the American College of Apothecaries conducted a survey of International Journal of Pharmaceutical Compounding subscribers in July 2005 to (1) assess the safety and efficacy of compounded preparations, (2) describe the types of compounding and other professional services that are offered by pharmacists, and (3) describe selected compounding pharmacies. In general, respondents reported few incidents of adverse events resulting from compounded preparations, and reported having offered a variety of compounding, professional, and patient care specialties se

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2008 Pg. 74-82	Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Author(s): Huffman DC, Holmes Erin R
Nov/Dec 2006 Pg. 462-468	Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Author(s): Huffman DC, Holmes Erin R
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2013 Pg. 339-343	Patient-centered Care as Value-added Service by Compounding Pharmacists Author(s): McPherson Timothy B, Fontane Patrick E, Day Jonathan R
May/Jun 2014 Pg. 208	The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Author(s): Miller David G
Jan/Feb 2018 Pg. 7-16	Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 4	PreScription: American Pharmacists Assocation and Compounding: New Partnership Reflects Old Ties Author(s): Menighan Thomas E
Nov/Dec 2015 Pg. 514-520	Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Author(s): Lobb William B, Wilkin Noel E, Holmes Erin R
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Jul/Aug 2020 Pg. 287-295	Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Author(s): McElhiney Linda F
Jul/Aug 2020 Pg. 296-297	Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Author(s): Brunner Scott
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Sep/Oct 2015 Pg. 375	The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Author(s): Miller David G
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott